Quest Diagnostics Incorporated (DGX) Stock Overview
NYSE · Healthcare · Diagnostics & Research
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Quest Diagnostics Incorporated
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It…
Source: Yahoo Finance
Sector & Industry
Quest Diagnostics Incorporated operates in the Healthcare sector, within the Diagnostics & Research industry group. It is listed on the NYSE exchange.
Quest Diagnostics Incorporated at a Glance
| Company | Quest Diagnostics Incorporated |
| Ticker | DGX |
| Exchange | NYSE |
| Currency | USD |
| Price | $237.14 |
| Market cap | $26.17B |
| P/E ratio (trailing) | 25.20 |
| EPS (trailing) | $9.41 |
| 52-week high | $247.19 |
| 52-week low | $171.18 |
| Dividend yield | 1.44% |
| Ex-dividend date | 06 Oct 2026 |
| Beta | 0.55 |
| Return on equity (ROE) | 14.60% |
| Debt-to-equity | 81.07% |
| Average volume | 955,131 |
| Shares outstanding | 110.37M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Employees | 46,000 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Frequently Asked Questions
- What is Quest Diagnostics Incorporated's current P/E ratio?
- Quest Diagnostics Incorporated (DGX) has a trailing P/E ratio of 25.20 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Quest Diagnostics Incorporated's market capitalisation?
- Quest Diagnostics Incorporated's market cap is $26.17B based on our latest snapshot. See how it ranks by market cap →
- What is DGX's 52-week range?
- Over the past 52 weeks, DGX has traded between $171.18 and $247.19. What does the 52-week range mean? →
- How volatile is Quest Diagnostics Incorporated compared to the market?
- Quest Diagnostics Incorporated has a beta of 0.55, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Quest Diagnostics Incorporated pay a dividend?
- Quest Diagnostics Incorporated's trailing annual dividend yield is 1.44%. Compare with other high-yield stocks →
- What exchange is DGX listed on?
- DGX is listed on the NYSE. Browse all NYSE-listed stocks →
- What sector is Quest Diagnostics Incorporated in?
- Quest Diagnostics Incorporated is classified in the Healthcare sector. Compare with Healthcare peers →
Working out potential returns or position sizes? Our payout and odds calculators handle the maths.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →